Gaxos.ai (NASDAQ: GXAI) adds $2.6M to at-the-market stock offering
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
Gaxos.ai Inc. expanded its existing at-the-market stock offering program with H.C. Wainwright & Co. by authorizing up to an additional $2,600,000 of common stock sales. This increase is on top of approximately $3,000,000 of common stock already sold under the same agreement.
The company also filed a new prospectus supplement covering these additional shares and provided a legal opinion from Sheppard Mullin Richter & Hampton LLP confirming the validity of the common stock to be issued.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 8.01, 9.01
2 items
Item 8.01
Other Events
Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
FAQ
What did Gaxos.ai Inc. (GXAI) announce in this 8-K filing?
Gaxos.ai Inc. increased the size of its existing at-the-market common stock offering program by up to an additional $2,600,000. This expansion builds on approximately $3,000,000 of common stock already sold under the prior authorization with H.C. Wainwright & Co..
How much additional stock can Gaxos.ai (GXAI) sell under the ATM program?
Gaxos.ai can now sell up to an additional $2,600,000 of its common stock through its at-the-market offering agreement. This amount is separate from the approximately $3,000,000 of common stock that has already been sold under the same agreement.
Who is Gaxos.ai’s sales agent for the expanded ATM stock offering?
H.C. Wainwright & Co., LLC acts as sales agent for Gaxos.ai’s at-the-market common stock offering. The February 4, 2026 update keeps the same agreement in place while increasing the maximum aggregate dollar amount of shares that may be issued.
What legal opinion supports Gaxos.ai’s additional $2.6 million ATM capacity?
A legal opinion from Sheppard Mullin Richter & Hampton LLP addresses the legality of the additional $2,600,000 in common stock issuable under the at-the-market program. This opinion is filed as Exhibit 5.1 and includes a related consent as Exhibit 23.1.
What is the purpose of Gaxos.ai’s prospectus supplement mentioned in the filing?
The prospectus supplement, referred to as the Current Prospectus Supplement, covers the additional $2,600,000 of Gaxos.ai common stock available under the at-the-market agreement. It updates offering disclosures so the company can continue selling shares into the market subject to that documentation.
Does the 8-K indicate that Gaxos.ai (GXAI) changed its ATM sales agent?
No change of sales agent is described. The at-the-market offering continues under the existing agreement with H.C. Wainwright & Co., LLC, originally dated January 23, 2026, with only the maximum aggregate offering amount being increased.